CERO THERAPEUTICS HOLDINGS, INC. Conversion of Stock, Shares Converted
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Conversion of Stock, Shares Converted of 625 shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-08-14
- 2025-06-30: Conversion of Stock, Shares Converted 6 month 625.00 shares.
- 2019-11-14: Conversion of Stock, Shares Converted 100.00 shares.
| Period end | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted 6 month |
|---|---|---|
| 2025-06-30 | 625.00 shares 10-Q · filed 2026-08-14 | |
| 2019-11-14 | 100.00 shares 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |